147 related articles for article (PubMed ID: 23828788)
1. Antitumor effect of miriplatin-lipiodol suspension/emulsion using a VX2 liver tumor model.
Tomozawa Y; Nitta N; Ohta S; Otani H; Watanabe S; Sonoda A; Tsuchiya K; Nitta-Seko A; Takahashi M; Murata K
Jpn J Radiol; 2013 Oct; 31(10):662-7. PubMed ID: 23828788
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
Okimoto K; Ogasawara S; Chiba T; Ooka Y; Oobu M; Azemoto R; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Yoshikawa M; Yokosuka O
Anticancer Res; 2013 Dec; 33(12):5603-9. PubMed ID: 24324105
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).
Watanabe S; Nitta N; Ohta S; Sonoda A; Otani H; Tomozawa Y; Nitta-Seko A; Tsuchiya K; Tanka T; Takahashi M; Murata K
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):399-405. PubMed ID: 21584842
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
Yasui D; Yamane A; Itoh H; Kobayashi M; Kumita SI
PLoS One; 2020; 15(8):e0222553. PubMed ID: 32756561
[TBL] [Abstract][Full Text] [Related]
5. Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin-lipiodol suspension for hepatocellular carcinoma.
Oguro S; Hashimoto S; Tanaka T; Inoue M; Nakatsuka S; Kuribayashi S; Asakura K; Kawachi S; Tanabe M; Kitagawa Y; Ebinuma H; Saito H; Hibi T
Jpn J Radiol; 2012 Nov; 30(9):735-42. PubMed ID: 22923183
[TBL] [Abstract][Full Text] [Related]
6. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits].
Liu X; Luo XP; Cao WT; Deng H
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156
[TBL] [Abstract][Full Text] [Related]
7. [Improvement of the viscosity and the intrahepatic distribution of miriplatin-lipiodol suspension].
Kishimoto S; Adachi S; Masui A; Suzuki R; Fukushima S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2101-3. PubMed ID: 25731436
[TBL] [Abstract][Full Text] [Related]
8. Stabilization Improves Theranostic Properties of Lipiodol
Deschamps F; Farouil G; Gonzalez W; Robic C; Paci A; Mir LM; Tselikas L; de Baère T
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):907-913. PubMed ID: 28271329
[TBL] [Abstract][Full Text] [Related]
9. [Influence of As2O3-lipiodol emulsion via transarterial embolization on a VX2 liver tumor model in rabbits].
Zou Y; Guo CG; Xu SL; Peng ZY; Sun JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 44(5):559-65. PubMed ID: 26713532
[TBL] [Abstract][Full Text] [Related]
10. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.
Hanada M; Baba A; Tsutsumishita Y; Noguchi T; Yamaoka T; Chiba N; Nishikaku F
Cancer Chemother Pharmacol; 2009 Aug; 64(3):473-83. PubMed ID: 19104812
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation after arterial injection of miriplatin-iodized oil suspension into swine liver: ablative zone size and tissue platinum concentration.
Yamanaka T; Takaki H; Nakatsuka A; Uchida K; Junji U; Fujimori M; Hasegawa T; Yoneda M; Shiraishi T; Sakuma H; Yamakado K
Cardiovasc Intervent Radiol; 2014 Aug; 37(4):1047-52. PubMed ID: 24232037
[TBL] [Abstract][Full Text] [Related]
12. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
13. Pickering-Emulsion for Liver Trans-Arterial Chemo-Embolization with Oxaliplatin.
Deschamps F; Harris KR; Moine L; Li W; Tselikas L; Isoardo T; Lewandowski RJ; Paci A; Huang N; de Baere T; Salem R; Larson AC
Cardiovasc Intervent Radiol; 2018 May; 41(5):781-788. PubMed ID: 29468287
[TBL] [Abstract][Full Text] [Related]
14. Safety and short-term therapeutic effects of miriplatin-lipiodol suspension in transarterial chemoembolization (TACE) for hepatocellular carcinoma.
Okabe K; Beppu T; Haraoka K; Oh-Uchida Y; Yamamura S; Tomiyasu S; Yamanaka T; Sano O; Masuda T; Chikamoto A; Fujiyama S; Baba H
Anticancer Res; 2011 Sep; 31(9):2983-8. PubMed ID: 21868548
[TBL] [Abstract][Full Text] [Related]
15. Transarterial Infusion of iRGD-Modified ZrO
Xie Y; Qi X; Xu K; Meng X; Chen X; Wang F; Zhong H
J Vasc Interv Radiol; 2019 Dec; 30(12):2026-2035.e2. PubMed ID: 31590966
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
[TBL] [Abstract][Full Text] [Related]
17. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of intraarterial infusion of tumor necrosis factor/lipiodol emulsion on hepatic tumor in rabbits.
Watanabe D; Ueo H; Inoue H; Matsuoka H; Honda M; Shinomiya Y; Takamatsu T; Akiyoshi T
Oncology; 1995; 52(1):76-81. PubMed ID: 7800348
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor model.
Gao F; Qian T; Chen MZ; Yin HB; Xu YL
Diagn Interv Radiol; 2015; 21(3):241-6. PubMed ID: 25858527
[TBL] [Abstract][Full Text] [Related]
20. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
